PUSH THE LIMITS OF SCIENCE
Our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries.
DUPIXENT® (dupilumab) Injection
EVKEEZA® (evinacumab-dgnb) Injection
EYLEA® HD (aflibercept) Injection
EYLEA® (aflibercept) Injection
INMAZEB® (atoltivimab, maftivimab, and odesivimab-ebgn) Injection
KEVZARA® (sarilumab) Injection
LIBTAYO® (cemiplimab-rwlc) Injection
PRALUENT® (alirocumab) Injection
Veopoz® (pozelimab-bbfg) Injection
AUTHORIZED FOR EMERGENCY USE ONLY
COVID-19 Treatment Resources
FDA Letter of Authorization
for EUA
Fact Sheet for U.S. Healthcare
Providers (English)
Our antibody combination is not currently authorized for use in any U.S. region. Please refer to the authorized Fact Sheet and FDA statement for additional details.